Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysisYannis K. Valtis, Karamjeet Sandhu, Rawan Faramand et al.|Blood|2025Cited by 2